• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡塔尔类风湿性关节炎患者的特征:一项横断面研究。

Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.

作者信息

Lutf Abdo, Poil Abdul R, Hammoudeh Mohammed

机构信息

Rheumatology Division, Department of Medicine, Hamad General Hospital, Doha, Qatar.

出版信息

Int J Rheum Dis. 2014 Jan;17(1):63-5. doi: 10.1111/1756-185X.12135. Epub 2013 Jul 16.

DOI:10.1111/1756-185X.12135
PMID:24472269
Abstract

OBJECTIVE

To describe the clinical characteristics, serologic, radiological and clinical disease activity, and modality of therapy in patients with rheumatoid arthritis (RA) at tertiary outpatient care in Qatar.

METHODS

The study design was cross-sectional where 100 consecutive cases who met 1987 American College of Rheumatology criteria for diagnosis of RA were enrolled in this study. Demographic data (sex, nationality and age) numbers of swollen and tender joints, X-rays and current medications were collected during outpatients visits to Hamad General Hospital. Disease Activity Score of 28 joints (DAS28) and Health Assessment Questionnaires (HAQ) scores were calculated. All patients with RA who were seen as rheumatology outpatients were invited to participate in the study.

RESULTS

One hundred patients were seen and examined during their follow-up at the outpatient clinic; data were collected and analyzed. Females represented 67% of all patients, 6% had more than six swollen joints, 9% had more than six tender joints. DAS28 and erythrocyte sedimentation rate (DAS28) calculation revealed 49% of patients were in remission (DAS28 < 2.6), 15% had low disease activity (DAS28 2.6-3.2) and 36% had DAS28 > 3.2.Mean HAQ score was 1.02. Rheumatoid factor (RF) was positive in 63%, while anti-cyclic citrullinated protein antibody (anti-CCP) was positive in 71%, and 49% were positive for both. Radiography of hands and feet during the previous year was done in 65% of patients: 11% of them had erosions. Sixty-six percent were on one synthetic disease-modifying anti-rheumatic drug (DMARD) and 27% where on more than one synthetic DMARD and 7% where on no DMRD. Glucocorticoids were used in 51% and 29% were on biologics.

CONCLUSION

Sixty-four percent of rheumatoid arthritis patients in Qatar were in remission or had low disease activity while the remaining 36% had active disease and among these patients 29% were on biologics.

摘要

目的

描述卡塔尔三级门诊护理中类风湿关节炎(RA)患者的临床特征、血清学、放射学及临床疾病活动度和治疗方式。

方法

本研究为横断面研究,纳入100例符合1987年美国风湿病学会RA诊断标准的连续病例。在患者到哈马德总医院门诊就诊期间,收集人口统计学数据(性别、国籍和年龄)、肿胀和压痛关节数、X线检查结果及当前用药情况。计算28个关节的疾病活动评分(DAS28)和健康评估问卷(HAQ)评分。所有在风湿病门诊就诊的RA患者均受邀参与本研究。

结果

100例患者在门诊随访期间接受了检查;收集并分析了数据。女性占所有患者的67%,6%的患者有超过6个肿胀关节,9%的患者有超过6个压痛关节。DAS28和红细胞沉降率(DAS28)计算结果显示,49%的患者病情缓解(DAS28<2.6),15%的患者疾病活动度低(DAS28 2.6 - 3.2),36%的患者DAS28>3.2。HAQ评分均值为1.02。类风湿因子(RF)阳性率为63%,抗环瓜氨酸肽抗体(抗CCP)阳性率为71%,49%的患者两者均为阳性。65%的患者在前一年进行了手足部X线检查:其中11%有骨质侵蚀。66%的患者使用一种合成改善病情抗风湿药(DMARD),27%的患者使用一种以上合成DMARD,7%的患者未使用DMARD。51%的患者使用糖皮质激素,29%的患者使用生物制剂。

结论

卡塔尔64%的类风湿关节炎患者病情缓解或疾病活动度低,其余36%的患者疾病活动,其中29%的患者使用生物制剂。

相似文献

1
Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.卡塔尔类风湿性关节炎患者的特征:一项横断面研究。
Int J Rheum Dis. 2014 Jan;17(1):63-5. doi: 10.1111/1756-185X.12135. Epub 2013 Jul 16.
2
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.21 世纪初早期类风湿关节炎患者的 5 年良好预后:来自 ESPOIR 队列的数据。
J Rheumatol. 2013 Oct;40(10):1650-7. doi: 10.3899/jrheum.121515. Epub 2013 Aug 15.
3
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?类风湿关节炎临床缓解患者的关节损伤进展:生物制剂比合成抗风湿药物效果更好吗?
J Rheumatol. 2014 Aug;41(8):1576-82. doi: 10.3899/jrheum.130767. Epub 2014 Jul 15.
4
American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.美国风湿病学会/欧洲抗风湿病联盟的类风湿关节炎缓解标准在评估 44 个关节时具有可靠的性能。
J Rheumatol. 2013 Aug;40(8):1254-8. doi: 10.3899/jrheum.130166. Epub 2013 Jun 15.
5
Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.四分之三未使用改善病情抗风湿药物的类风湿关节炎患者在12个月时达到28个关节疾病活动评分缓解:芬兰类风湿关节炎队列研究结果
Scand J Rheumatol. 2017 Nov;46(6):425-431. doi: 10.1080/03009742.2016.1266029. Epub 2017 Apr 3.
6
Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.类风湿关节炎患者足部和踝关节关节炎的患病率及其对临床指标的影响:一项横断面研究。
BMC Musculoskelet Disord. 2019 Sep 11;20(1):420. doi: 10.1186/s12891-019-2773-z.
7
Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.类风湿关节炎中、高度疾病活动患者实现疾病最佳控制的障碍。
Arthritis Care Res (Hoboken). 2014 Feb;66(2):190-6. doi: 10.1002/acr.22108.
8
Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre.托珠单抗治疗难治性类风湿关节炎的疗效和安全性:来自单个中心的真实队列研究。
Clin Exp Rheumatol. 2014 Jul-Aug;32(4):460-4. Epub 2014 Jun 23.
9
Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.不同标准定义的类风湿关节炎缓解并不与炎症标志物一致。
Int J Rheum Dis. 2013 Jun;16(3):291-6. doi: 10.1111/1756-185X.12091. Epub 2013 Jun 8.
10
The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.在常规护理中,评估类风湿关节炎活动的患者自报告问卷和综合疾病指标的比较反应性。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6):912-21. Epub 2012 Dec 17.

引用本文的文献

1
Impact of Biological Therapy on Fatigue, Functional Status, and Health-Related Quality of Life in Rheumatoid Arthritis Patients: Results from Real-Life Practice.生物疗法对类风湿关节炎患者疲劳、功能状态及健康相关生活质量的影响:来自现实生活实践的结果
Saudi J Med Med Sci. 2025 Jul-Sep;13(3):189-196. doi: 10.4103/sjmms.sjmms_747_24. Epub 2025 Jul 14.
2
Prevalence of rheumatoid arthritis and diagnostic validity of a prediction score, in patients visiting orthropedic clinics in the Madinah region of Saudi Arabia: a retrospective cross-sectional study.在沙特阿拉伯麦加地区的骨科诊所就诊的患者中,类风湿关节炎的流行率和预测评分的诊断准确性:一项回顾性横断面研究。
PeerJ. 2022 Nov 15;10:e14362. doi: 10.7717/peerj.14362. eCollection 2022.
3
Perceptions and Challenges Experienced by African Physicians When Prescribing Methotrexate for Rheumatic Disease: An Exploratory Study.
非洲医生在为风湿性疾病开甲氨蝶呤时的认知与挑战:一项探索性研究
ACR Open Rheumatol. 2021 Aug;3(8):522-530. doi: 10.1002/acr2.11290. Epub 2021 Jul 1.
4
Saudi cultural adaptation of the "compliance questionnaire of Rheumatology" for Rheumatoid arthritis patients on disease modifying anti-rheumatic drugs (DMARDs).针对类风湿关节炎患者使用改善病情抗风湿药物(DMARDs)情况的《风湿病依从性调查问卷》的沙特文化适应性研究。
Saudi Pharm J. 2021 May;29(5):377-383. doi: 10.1016/j.jsps.2021.03.007. Epub 2021 Mar 24.
5
The Use of Infliximab (Remicade®) for the Treatment of Rheumatic Diseases at a Tertiary Center in Lebanon: A 17-Year Retrospective Chart Review.英夫利昔单抗(类克®)在黎巴嫩一家三级中心用于治疗风湿性疾病:一项为期17年的回顾性图表审查。
Mediterr J Rheumatol. 2020 Dec 22;31(4):400-405. doi: 10.31138/mjr.31.4.400. eCollection 2020 Dec.
6
Accessibility to biologics and its impact on disease activity and quality of life in patients with rheumatoid arthritis in Kuwait.科威特类风湿关节炎患者使用生物制剂的可及性及其对疾病活动度和生活质量的影响。
Clin Rheumatol. 2021 May;40(5):1759-1765. doi: 10.1007/s10067-020-05444-2. Epub 2020 Oct 12.
7
Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates.阿联酋一个队列中类风湿关节炎的人口统计学和临床模式
Int J Rheumatol. 2019 Sep 25;2019:3057578. doi: 10.1155/2019/3057578. eCollection 2019.
8
Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis.临床深度缓解及其在大量类风湿关节炎患者中的相关因素。
Chin Med J (Engl). 2019 May 5;132(9):1009-1014. doi: 10.1097/CM9.0000000000000227.
9
Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.在一个大型阿拉伯患者队列中,类风湿关节炎的流行病学和治疗模式。
PLoS One. 2018 Dec 19;13(12):e0208240. doi: 10.1371/journal.pone.0208240. eCollection 2018.
10
An assessment of the current treatment landscape for rheumatology patients in Qatar: Recognising unmet needs and moving towards solutions.卡塔尔风湿病患者当前治疗状况评估:认识未满足的需求并寻求解决方案。
J Int Med Res. 2017 Apr;45(2):733-743. doi: 10.1177/0300060516686872. Epub 2017 Mar 7.